BalanCD™ Gal Supplement
Supplier: FUJIFILM IRVINE SCIENTIFIC INC.
The ability to produce high product titers and excellent protein quality is critical for the generation of effective therapeutic biomolecules. Glycosylation modifications, including galactosylation, help to achieve this critical quality aspect by enhancing protein characteristics and antibody efficacy. BalanCD™ Gal Supplement delivers increased galactosylation, through the addition of N-linked glycan moieties, while supporting an efficient, streamlined workflow.
Compatible with any basal growth medium for a wide range of cell lines
Simplified, scalable protocol
Enhanced formula requires a lower concentration to achieve desired outcome - contributing to improved efficiency and streamlined workflow
Simple, single feeding schedule
Chemically-defined, animal component-free, and cGMP manufactured to support commercial applications
Designed to incorporate seamlessly into the BalanCD CHO Media
Platform for efficient growth and production
Packaging:
Store at 15 to 30 °C
Shelf life: 24 months from date of manufacture
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...